New research suggests that factors like age, sex, body fat and the amount of sugar in your blood play a significant role in the progression from pre-diabetes to a type 2 diabetes diagnosis.

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...